Gigi Georgiana Huang

Array ( [id] => 9192136 [patent_doc_number] => 20130331451 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-12-12 [patent_title] => 'High Concentration Baclofen Preparations' [patent_app_type] => utility [patent_app_number] => 13/961352 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7174 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961352 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9369911 [patent_doc_number] => 20140079784 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-20 [patent_title] => 'AEROSOLIZED LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/960915 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 48055 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13960915 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9319384 [patent_doc_number] => 20140051722 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-20 [patent_title] => 'TOPICAL LFA-1 ANTAGONISTS FOR USE IN LOCALIZED TREATMENT OF IMMUNE RELATED DISORDERS' [patent_app_type] => utility [patent_app_number] => 13/961117 [patent_app_country] => US [patent_app_date] => 2013-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 29 [patent_figures_cnt] => 29 [patent_no_of_words] => 46333 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13961117 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9212712 [patent_doc_number] => 20140011890 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-09 [patent_title] => 'METHODS AND COMPOSITIONS FOR TREATING NEUROPATHIES' [patent_app_type] => utility [patent_app_number] => 13/952183 [patent_app_country] => US [patent_app_date] => 2013-07-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 17661 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13952183 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9943653 [patent_doc_number] => 08992952 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-03-31 [patent_title] => 'Compositions for delivery of therapeutics into the eyes and methods for making and using same' [patent_app_type] => utility [patent_app_number] => 13/933807 [patent_app_country] => US [patent_app_date] => 2013-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 3 [patent_no_of_words] => 12962 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 102 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13933807 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10820375 [patent_doc_number] => 20160166539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2016-06-16 [patent_title] => 'A NOVEL COMPOSITION FOR NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)' [patent_app_type] => utility [patent_app_number] => 14/782609 [patent_app_country] => US [patent_app_date] => 2013-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 6140 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14782609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9135727 [patent_doc_number] => 20130296442 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'LUTEIN/ZEAXANTHIN FOR GLARE PROTECTION' [patent_app_type] => utility [patent_app_number] => 13/917889 [patent_app_country] => US [patent_app_date] => 2013-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1768 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917889 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9122166 [patent_doc_number] => 20130289088 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-31 [patent_title] => 'ESTER PRO-DRUGS OF [3-(1-(1H-IMIDAZOL-4-YL)ETHYL)-2-METHYLPHENYL] METHANOL FOR LOWERING INTRAOCULAR PRESSURE' [patent_app_type] => utility [patent_app_number] => 13/916888 [patent_app_country] => US [patent_app_date] => 2013-06-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10577 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916888 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9384700 [patent_doc_number] => 20140088182 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-03-27 [patent_title] => 'INFLAMMATORY EYE DISEASE' [patent_app_type] => utility [patent_app_number] => 13/916207 [patent_app_country] => US [patent_app_date] => 2013-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 7389 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13916207 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9042341 [patent_doc_number] => 20130244978 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-19 [patent_title] => 'OPHTHALMIC COMPOSITION' [patent_app_type] => utility [patent_app_number] => 13/889576 [patent_app_country] => US [patent_app_date] => 2013-05-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14714 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13889576 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9134361 [patent_doc_number] => 20130295075 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-07 [patent_title] => 'COMPOSITIONS AND METHODS OF TREATING GLAUCOMA' [patent_app_type] => utility [patent_app_number] => 13/887217 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 9842 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887217 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9055283 [patent_doc_number] => 20130252997 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-26 [patent_title] => 'TREATING UNWANTED OCULAR CONDITION USING AN ASCOMYCIN MACROLACTAM' [patent_app_type] => utility [patent_app_number] => 13/887057 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3999 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13887057 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9069434 [patent_doc_number] => 20130261190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-10-03 [patent_title] => 'Ophthalmic Compositions with Biguanide and PEG-Glycerol Esters' [patent_app_type] => utility [patent_app_number] => 13/886571 [patent_app_country] => US [patent_app_date] => 2013-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7586 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13886571 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9162143 [patent_doc_number] => 20130310420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-11-21 [patent_title] => 'STABLE FORMULATIONS OF PITAVASTATIN' [patent_app_type] => utility [patent_app_number] => 13/865118 [patent_app_country] => US [patent_app_date] => 2013-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4380 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13865118 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16040939 [patent_doc_number] => 10682320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-06-16 [patent_title] => Method for inhibiting osteoclast development [patent_app_type] => utility [patent_app_number] => 13/864438 [patent_app_country] => US [patent_app_date] => 2013-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 11 [patent_no_of_words] => 7942 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 66 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13864438 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9281330 [patent_doc_number] => 20140031298 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-01-30 [patent_title] => 'Compositions and Methods for Localized Therapy of the Eye' [patent_app_type] => utility [patent_app_number] => 13/857707 [patent_app_country] => US [patent_app_date] => 2013-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7252 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13857707 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8854283 [patent_doc_number] => 20130143958 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-06 [patent_title] => 'DOSAGE UNIT COMPRISING A PROSTAGLANDIN ANALOG FOR TREATING CONSTIPATION' [patent_app_type] => utility [patent_app_number] => 13/754138 [patent_app_country] => US [patent_app_date] => 2013-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4651 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13754138 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8842023 [patent_doc_number] => 20130137651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-30 [patent_title] => 'GEL USEFUL FOR THE DELIVERY OF OPHTHALMIC DRUGS' [patent_app_type] => utility [patent_app_number] => 13/749790 [patent_app_country] => US [patent_app_date] => 2013-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4795 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749790 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9019933 [patent_doc_number] => 08529916 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-09-10 [patent_title] => 'High concentration baclofen preparations' [patent_app_type] => utility [patent_app_number] => 13/743081 [patent_app_country] => US [patent_app_date] => 2013-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7141 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13743081 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8892296 [patent_doc_number] => 20130165480 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-27 [patent_title] => 'Stabilized and Preserved Ketotifen Ophthalmic Compositions' [patent_app_type] => utility [patent_app_number] => 13/739060 [patent_app_country] => US [patent_app_date] => 2013-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2481 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13739060 [rel_patent_id] =>[rel_patent_doc_number] =>)